Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

4.16
-0.3050-6.84%
Volume:364.70K
Turnover:1.56M
Market Cap:28.15M
PE:-0.60
High:4.50
Open:4.40
Low:4.11
Close:4.46
Loading ...

BriaCell Announces Completion of 15:1 Share Consolidation

GlobeNewswire
·
28 Jan

BriaCell Plans Share Consolidation for Nasdaq Compliance

TIPRANKS
·
04 Jan

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

GlobeNewswire
·
04 Jan

BriaCell Announces Proposed Effective Date of Share Consolidation

GlobeNewswire
·
04 Jan

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

Simply Wall St.
·
19 Dec 2024

BriaCell Adapts Meeting Procedures Amid Postal Strike

TIPRANKS
·
18 Dec 2024

Briacell Therapeutics Corp reports results for the quarter ended October 31 - Earnings Summary

Reuters
·
17 Dec 2024

BriaCell Therapeutics Reports Quarterly Financial Loss

TIPRANKS
·
17 Dec 2024

BriaCell Therapeutics Closes $5.5 Million Offering

TIPRANKS
·
14 Dec 2024

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

GlobeNewswire
·
13 Dec 2024

BRIEF-Briacell Therapeutics Prices Public Offering Of 7.4 Mln Shares And Warrants At $0.75 Each

Reuters
·
12 Dec 2024

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

GlobeNewswire
·
12 Dec 2024

BriaCell Therapeutics Plans Public Offering

TIPRANKS
·
12 Dec 2024

BriaCell announces common shares, warrants offering

TIPRANKS
·
12 Dec 2024

Briacell Therapeutics Corp expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
11 Dec 2024

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire
·
02 Dec 2024

BriaCell Highlights Promising Breast Cancer Trial Results

TIPRANKS
·
26 Nov 2024

BriaCell to highlight OS, clinical benefit data of Bria-IMT in MBC patients

TIPRANKS
·
26 Nov 2024

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswire
·
26 Nov 2024

BriaCell director Marc Lustig resigns

TIPRANKS
·
25 Nov 2024